Glenmark Shares Fall as DGCI Sends Notice on Overpricing of Covid-19 Drug FabiFlu

The Mumbai-based company reduced the price of FabiFlu to 75 rupees per tablet last week for restricted emergency use in patients with mild-to-moderate COVID-19 symptoms in India.

from Top India News- News18.com https://ift.tt/3jkkukN